ISN Webinar: Advancements in C3 Glomerulopathy (C3G)

  • Register
    • Non-member - Free!
    • Member - Free!
    • Subscriber - Free!
    • Free trial - Free!

>span class="NormalTextRun SCXW72858246 BCX0" data-ccp-parastyle="Table Paragraph">webinar will provide a comprehensive view of C3 Glomerulopathy (C3G). It will first discuss the complexities of C3G, including classification (dense deposit disease vs. C3 glomerulonephritis), natural history, and biopsy. It will then cover the latest clinical trial data before discussing how new therapeutic agents will fit into the treatment landscape. 

Learning objectives:

- Provide an overview of C3G including classification, natural history and biopsy
- Explore the latest clinical trial data
- Consider how new agents will fit into the treatment landscape 

This webinar is supported by Novartis.

David Kavanagh

UK

Alison Ma

Hong Kong

Andrew Bomback

USA

Key:

Complete
Failed
Available
Locked
ISN Webinar: Advancements in C3 Glomerulopathy (C3G)
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available